Severe Myoclonic Epilepsy In Infancy — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for severe myoclonic epilepsy in infancy. 32 active patents protecting 1 drugs from 1+ originators. First major cliff: 2035. Daily refresh.

1
Approved drugs
32
Active US patents
48/100
Avg vulnerability
$800M
Annual revenue covered

Originators in Severe Myoclonic Epilepsy In Infancy

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Jazz Pharms Res 32 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating severe myoclonic epilepsy in infancy. Each bar = one year. Y-axis scaled to peak year (27 patents).

27
35
2
39
3
41

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Epidiolex
CANNABIDIOL
 Jazz Pharms Res 32 48 $800M 2035-06-17

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
12064399 Epidiolex method of use 58 2035-06-17
11963937 Epidiolex method of use 58 2035-06-17
11865102 Epidiolex method of use 58 2039-04-26
12102619 Epidiolex method of use 58 2041-03-01
11633369 Epidiolex method of use 53 2035-06-17
11357741 Epidiolex method of use 53 2035-06-17
11701330 Epidiolex method of use 53 2035-06-17
11446258 Epidiolex method of use 53 2035-06-17
11311498 Epidiolex method of use 53 2035-06-17
11766411 Epidiolex method of use 53 2035-06-17

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
10709673 Epidiolex formulation 25 2035-06-17
11160795 Epidiolex method of use 45 2041-03-01
11096905 Epidiolex method of use 45 2035-10-13
11065209 Epidiolex method of use 45 2035-10-13
10918608 Epidiolex method of use 45 2035-10-13
10966939 Epidiolex method of use 45 2035-06-17
10603288 Epidiolex method of use 45 2035-06-17
10709674 Epidiolex method of use 45 2035-06-17
10849860 Epidiolex method of use 45 2035-06-17
9956185 Epidiolex method of use 45 2035-06-17

Related